Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and Type II diabetes

被引:169
|
作者
Yuan, X
Yamada, K
Ishiyama-Shigemoto, S
Koyama, W
Nonaka, K
机构
[1] Kurume Univ, Div Endocrinol & Metab, Dept Med, Sch Med, Kurume, Fukuoka 8300011, Japan
[2] Kumamoto Red Cross Hlth Care Ctr, Kumamoto, Japan
关键词
serotonin; 5-HT2C receptor; promoter; polymorphism; obesity;
D O I
10.1007/s001250050056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Polymorphisms in the upstream region of the 5-MT2C receptor gene could play a part in the development of obesity. Methods. We screened the upstream region from 27 men by the single strand conformational polymorphism analysis and PCR-direct sequencing and then genotyped 466 non-obese (body mass index < 28 kg/ m(2)) and 123 obese (greater than or equal to 28 kg/m(2)) men including 138 patients with Type II (non-insulin-dependent) diabetes mellitus. Results. Three loci of single nucleotide substitution (G-->A at -995, C-->T at -759, G-->C at -697) and a (GT)n dinucleotide repeat polymorphism at -1,027 were identified. The frequency of -995/-759 and -697 variants was higher in non-obese subjects and that of -995/-759 variants in non-diabetic subjects. In the dinucleotide repeat locus, five alleles were detected including Z containing 17 repeats. The Z-6 allele was more common in non-obese subjects and the Z + 2 allele in obese subjects. Haplotype 3 (Z-6, -995A, -759T, -697C) was associated with leanness (p = 0.02) and the absence of diabetes (p = 0.033) and haplotype 9 (Z + 2, -995G, -759C, -697G) with obesity (p = 0.007). Haplotype 2 (Z-6, -995G, -759C, -697C) tended to be more common in nonobese subjects. A luciferase reporter assay showed that haplotype 2 and haplotype 3 had 1.44- or 2.58-fold higher promoter activities than the most common haplotype 6 (Z, -995G, -759C, -697G). Conclusion/interpretation. The haplotypes containing the nucleotide substitutions could be associated with higher transcription levels of the gene and thereby with resistance to obesity and Type II diabetes. Promoter polymorphisms of the 5-MT2C receptor gene may play an important part in genetic predisposition to the disorders.
引用
收藏
页码:373 / 376
页数:4
相关论文
共 50 条
  • [41] Identification of fluorinated (R)-(-)-aporphine derivatives as potent and selective ligands at serotonin 5-HT2C receptor
    Xu, Yulong
    Sromek, Anna W.
    Neumeyer, John L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (02) : 230 - 233
  • [42] Association of antipsychotic drug-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene
    Reynolds, GP
    Zhang, ZJ
    Zhang, XB
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 158 - 159
  • [43] Cloning and expression of a zebrafish 5-HT2C receptor gene
    Schneider, Henning
    Fritzky, Luke
    Williams, Jesse
    Heumann, Christine
    Yochum, Marissa
    Pattar, Kala
    Noppert, Grace
    Mock, Vanessa
    Hawley, Eric
    GENE, 2012, 502 (02) : 108 - 117
  • [44] Schizophrenia, chronic hospitalization and the 5-HT2C receptor gene
    Segman, RH
    Ebstein, RP
    HerescoLevy, U
    Gorfine, M
    Avnon, M
    Gur, E
    Nemanov, L
    Lerer, B
    PSYCHIATRIC GENETICS, 1997, 7 (02) : 75 - 78
  • [45] Dynamic 5-HT2C Receptor Editing in a Mouse Model of Obesity
    Schellekens, Harriet
    Clarke, Gerard
    Jeffery, Ian B.
    Dinan, Timothy G.
    Cryan, John F.
    PLOS ONE, 2012, 7 (03):
  • [46] 5-HT2C receptor agonists as potential drugs for the treatment of obesity
    Bickerdike, MJ
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (08) : 885 - 897
  • [47] Association of a polymorphism of the 5HT2A receptor gene promoter region with alcohol dependence
    T Nakamura
    S Matsushita
    N Nishiguchi
    M Kimura
    A Yoshino
    S Higuchi
    Molecular Psychiatry, 1999, 4 : 85 - 88
  • [48] Association of a polymorphism of the 5HT2A receptor gene promoter region with alcohol dependence
    Nakamura, T
    Matsushita, S
    Nishiguchi, N
    Kimura, M
    Yoshino, A
    Higuchi, S
    MOLECULAR PSYCHIATRY, 1999, 4 (01) : 85 - 88
  • [49] Serotonin 5-HT2c receptor mutant mice develop obesity, a prediabetic state and moderate leptin insensitivity
    Nonogaki, K
    Strack, AM
    Dallman, MF
    Tecott, LH
    DIABETES, 1998, 47 : A320 - A320
  • [50] Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation
    E.-P. Pälvimäki
    Hannu Majasuo
    Mikko Kuoppamäki
    Pekka T. Männistö
    Erkka Syvälahti
    Jarmo Hietala
    Psychopharmacology, 1998, 136 : 99 - 104